Cargando…

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

BACKGROUND: Despite the psychosocial challenges of living with psoriasis many patients may not be able to access appropriate services to manage these challenges. Mobile health interventions may be helpful as a means to support patients in managing the impact of their condition. OBJECTIVE: To conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortune, D. G., Ravnkilde, V., Ryan, S., Ramsay, B., Clough, S., Richards, H. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168014/
https://www.ncbi.nlm.nih.gov/pubmed/35677915
http://dx.doi.org/10.1002/ski2.103
_version_ 1784720906020454400
author Fortune, D. G.
Ravnkilde, V.
Ryan, S.
Ramsay, B.
Clough, S.
Richards, H. L.
author_facet Fortune, D. G.
Ravnkilde, V.
Ryan, S.
Ramsay, B.
Clough, S.
Richards, H. L.
author_sort Fortune, D. G.
collection PubMed
description BACKGROUND: Despite the psychosocial challenges of living with psoriasis many patients may not be able to access appropriate services to manage these challenges. Mobile health interventions may be helpful as a means to support patients in managing the impact of their condition. OBJECTIVE: To conduct a preliminary examination of the feasibility and acceptability of a bespoke psoriasis‐specific digital therapeutic solution (hereafter termed Allay), and to provide initial data on psychological changes pre‐post. METHODS: Phase one proof of concept pre‐post study. Eligible patients were provided with Allay on their smartphone and assessed at baseline and at 12 weeks on a range of indices of well‐being. Participants experiences on usability were collected by telephone interview at 4 weeks, 8 and 12 weeks. RESULTS: Out of 66 participants recruited, 59 persisted in using Allay after the familiarisation phase, and 34 participants completed the 12 weeks programme. Participants showed a statistically significant improvement between induction and the end of the 12 weeks programme on Quality of life, Resilience, Perceptions of ‘Overall impact’ of psoriasis, and ‘Emotional impact’. There was a significant change over the course of using Allay for symptoms of depression but not anxiety. While there was an interaction effect of changes in severity of psoriasis symptoms over the course of the study for dermatology‐specific measures, there was no interaction between such changes in psoriasis symptoms and changes in depression, resilience or beliefs in emotional impact. CONCLUSIONS: Study results suggest that the use of Allay as an adjunct to medical management of psoriasis may help patients improve resilience, mood, beliefs about their condition and enhance their quality of life. Given that this is a phase one proof of concept study, and our rates of attrition further research is necessary to examine comparative effectiveness and stability of these findings.
format Online
Article
Text
id pubmed-9168014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91680142022-06-07 A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study Fortune, D. G. Ravnkilde, V. Ryan, S. Ramsay, B. Clough, S. Richards, H. L. Skin Health Dis Original Articles BACKGROUND: Despite the psychosocial challenges of living with psoriasis many patients may not be able to access appropriate services to manage these challenges. Mobile health interventions may be helpful as a means to support patients in managing the impact of their condition. OBJECTIVE: To conduct a preliminary examination of the feasibility and acceptability of a bespoke psoriasis‐specific digital therapeutic solution (hereafter termed Allay), and to provide initial data on psychological changes pre‐post. METHODS: Phase one proof of concept pre‐post study. Eligible patients were provided with Allay on their smartphone and assessed at baseline and at 12 weeks on a range of indices of well‐being. Participants experiences on usability were collected by telephone interview at 4 weeks, 8 and 12 weeks. RESULTS: Out of 66 participants recruited, 59 persisted in using Allay after the familiarisation phase, and 34 participants completed the 12 weeks programme. Participants showed a statistically significant improvement between induction and the end of the 12 weeks programme on Quality of life, Resilience, Perceptions of ‘Overall impact’ of psoriasis, and ‘Emotional impact’. There was a significant change over the course of using Allay for symptoms of depression but not anxiety. While there was an interaction effect of changes in severity of psoriasis symptoms over the course of the study for dermatology‐specific measures, there was no interaction between such changes in psoriasis symptoms and changes in depression, resilience or beliefs in emotional impact. CONCLUSIONS: Study results suggest that the use of Allay as an adjunct to medical management of psoriasis may help patients improve resilience, mood, beliefs about their condition and enhance their quality of life. Given that this is a phase one proof of concept study, and our rates of attrition further research is necessary to examine comparative effectiveness and stability of these findings. John Wiley and Sons Inc. 2022-04-05 /pmc/articles/PMC9168014/ /pubmed/35677915 http://dx.doi.org/10.1002/ski2.103 Text en © 2022 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Fortune, D. G.
Ravnkilde, V.
Ryan, S.
Ramsay, B.
Clough, S.
Richards, H. L.
A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study
title A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study
title_full A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study
title_fullStr A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study
title_full_unstemmed A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study
title_short A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study
title_sort digital therapeutic for management of psychosocial aspects of psoriasis: a pre‐post proof of concept study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168014/
https://www.ncbi.nlm.nih.gov/pubmed/35677915
http://dx.doi.org/10.1002/ski2.103
work_keys_str_mv AT fortunedg adigitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT ravnkildev adigitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT ryans adigitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT ramsayb adigitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT cloughs adigitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT richardshl adigitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT fortunedg digitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT ravnkildev digitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT ryans digitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT ramsayb digitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT cloughs digitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy
AT richardshl digitaltherapeuticformanagementofpsychosocialaspectsofpsoriasisaprepostproofofconceptstudy